LIF and neoplasm: Given the importance of circulating LIF as a predictive marker of treatment response we further sought to investigate secreted levels of LIF from OAC patient tumours using a human ex-vivo model using treatment-naïve OAC patient tumour biopsies (patient cohort outlined in Supplementary Table 3).